The global IVD quality control market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making. The growth of the IVD quality control market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect the market growth
The product & service segment holds the highest share of the total IVD quality control market during the forecast period. Based on product & service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services.The quality control products segment accounted for the largest share of the IVD quality control market in 2020.
The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.
Serum based controls drive the growth of the quality control products segment during the forecast period. Based on type, the IVD quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and others. Serum/plasma-based controls are highly preferred by laboratories; this segment accounted for the largest share of the quality control products market in 2020. The greater uptake of serum/plasma-based quality controls among laboratories and the wide application areas of these controls for various IVD tests are driving the market growth
Molecular diagnostics segment accounted for the highest CAGR of the global IVD quality control market Based on technology, the IVD quality control market is broadly segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other technologies.The molecular diagnostics segment has the highest CAGR for the forecast period.
With the increased non-communicable disease burden, molecular diagnostic tests have been used in the field of oncology widely. Technological advancement in the field of molecular diagnostics is another driver for the growth of this industry.
Third-party controls accounted for the highest share for the IVD quality control market Based on manufacturer, the IVD quality control market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global IVD quality control market in 2020. The large share of this segment can be attributed to the increasing use of third-party quality controls across the globe to verify the accuracy and reliability of tests
Based on end users, hospitals accounted for the highest share of the global IVD quality control market during the forecast period. The key end users of IVD quality controls studied in this report include hospitals, clinical laboratories, research & academic institutes, and other end users. The hospitals segment accounted for the largest share of the IVD quality control market in 2020, owing to the large volume of diagnostic tests carried out in hospitals.
North America is expected to account for the highest share for players operating in the global IVD quality control market Geographically, the global IVD quality control market studied in this report is divided into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.In 2020, North America accounted for the largest share of the global IVD quality control market, followed by Europe.
The APAC region has the highest CAGR of the global IVD quality control market.The Asia Pacific is considered the most lucrative market for IVD quality controls, owing to the region’s large patient population and rising healthcare needs.
Market players are focusing on improving laboratory test quality in emerging APAC countries by working with local government bodies, agencies, and academic societies to offer external QC for standardizing laboratory testing procedures and ensure accuracy.
Break of primary participants was as mentioned below: • By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10% • By Designation – C-level–30%, Director-level–50%, Others–20% • By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%
Key players in the IVD quality control Market Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
Research Coverage: The report analyzes the IVD quality control market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, manufacturer type, end user, and region.The report also includes a product portfolio matrix of various IVD quality control available in the market.
The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers: • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global IVD quality control market. The report analyzes this market by product, technology, manufacturer type, end user, and region. • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global IVD quality control market • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, manufacturer type, end user, and region. • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD quality control market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global IVD quality control market.
Our reports have been used by over 10K customers, including:
The growth of the UAE in vitro diagnostics market can be attributed to factors, such as high prevalence of chronic and infectious diseases. Chronic diseases, such as cancer, diabetes, and various respiratory diseases, are posing as a global challenge. According to the International Diabetes Federation, currently, 55 million people...
The global in-vitro diagnostics market was valued at approximately USD 68,410 million in 2020, and it is expected to witness a revenue of USD 91,250 million in 2026, with a CAGR of 4.90% over the forecast period. The COVID-19 pandemic turned the spotlight on in-vitro diagnostics, since there is an increasing demand for the IVD kits...
198 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
The Middle East and Africa molecular quality controls market is expected to reach US$ 12.52 million by 2028 from US$ 6.87 million in 2021; it is estimated to grow at a CAGR of 9.0% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel...
Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,242 Million by 2027. Saudi Arabia is the largest IVD market in the GCC region. As in other countries, Saudi Arabia is facing the challenges of fighting with infectious disease including HBV, TB, HCV, COVID-19 and HIV, as well as various chronic disease and cancer. In-vitro...
The in-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027. Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention....
The in-vitro diagnostics market in Europe is expected to grow from US$ 15,973.0 million in 2019 to US$ 22,221.8 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027. The in-vitro diagnostics market has accounted for a significant market share in the healthcare industry during the COVID-19 pandemic. The market growth...
The in-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. For instance, according to the research conducted by American...
The in-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. Incidence of chronic diseases such as cancers, chronic respiratory diseases, diabetes, and heart disease is growing due to biological risk factors,...
The in-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. Diabetes in adults generates higher risk of functional...
In Vitro Diagnostics
Chronic Disease Prevalence
Infectious Disease Incidence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.